Published in Hum Mol Genet on February 13, 2008
Transient receptor potential channelopathies. Pflugers Arch (2010) 1.40
Phosphoinositide regulation of non-canonical transient receptor potential channels. Cell Calcium (2009) 1.29
The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol (2009) 1.08
Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P₂. FASEB J (2011) 1.02
Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion. PLoS One (2013) 0.87
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol (2013) 0.86
Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5. PLoS One (2013) 0.85
Exploration of signals of positive selection derived from genotype-based human genome scans using re-sequencing data. Hum Genet (2011) 0.85
The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx. Am J Physiol Renal Physiol (2009) 0.84
Human SLC26A1 gene variants: a pilot study. ScientificWorldJournal (2013) 0.83
Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers. Cancer Epidemiol Biomarkers Prev (2011) 0.81
Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease. Am J Physiol Cell Physiol (2012) 0.81
Icariin attenuates glucocorticoid-induced bone deteriorations, hypocalcemia and hypercalciuria in mice. Int J Clin Exp Med (2015) 0.75
Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet (2006) 2.96
Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia. Hypertension (2013) 2.70
Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. Kidney Int (2009) 2.39
Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int (2010) 2.35
Outcome of home haemodialysis patients: a case-cohort study. Nephrol Dial Transplant (2005) 2.21
Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int (2008) 2.00
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest (2004) 1.87
Molecular clock is involved in predictive circadian adjustment of renal function. Proc Natl Acad Sci U S A (2009) 1.84
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch (2003) 1.75
Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant (2012) 1.71
α-Ketoglutarate regulates acid-base balance through an intrarenal paracrine mechanism. J Clin Invest (2013) 1.66
Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res (2007) 1.56
The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest (2003) 1.53
Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology (2006) 1.52
Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients. Am J Hypertens (2008) 1.51
Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant (2005) 1.50
High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome. Nephrol Dial Transplant (2009) 1.49
Divalent metal-ion transporter DMT1 mediates both H+ -coupled Fe2+ transport and uncoupled fluxes. Pflugers Arch (2005) 1.46
The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans. Eur Heart J (2006) 1.45
The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant (2005) 1.44
Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome. Nephrol Dial Transplant (2002) 1.44
Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration. Artif Organs (2009) 1.43
Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens (2012) 1.43
Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem J (2007) 1.38
Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology (2003) 1.37
Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant (2009) 1.34
The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. Eur J Pharmacol (2003) 1.33
Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Aspects Med (2013) 1.33
Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest (2002) 1.30
FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone. J Bone Miner Res (2011) 1.25
Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci U S A (2009) 1.23
Genetic hypercalciuria. J Am Soc Nephrol (2005) 1.23
Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun (2008) 1.22
The circadian clock modulates renal sodium handling. J Am Soc Nephrol (2012) 1.21
Sodium-dependent ascorbic acid transporter family SLC23. Pflugers Arch (2003) 1.20
Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J (2005) 1.18
Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons. J Biol Chem (2003) 1.17
Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol (2009) 1.15
CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells. J Physiol (2004) 1.14
First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol (2008) 1.12
The SLC14 gene family of urea transporters. Pflugers Arch (2003) 1.12
The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther (2008) 1.10
Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. Hum Mol Genet (2010) 1.10
New view at C. Nat Med (2002) 1.09
Identification of mammalian proline transporter SIT1 (SLC6A20) with characteristics of classical system imino. J Biol Chem (2005) 1.09
Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets. J Bone Miner Res (2013) 1.08
Characterization of a branched-chain amino-acid transporter SBAT1 (SLC6A15) that is expressed in human brain. Biochem Biophys Res Commun (2005) 1.08
Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07
SLC11 family of H+-coupled metal-ion transporters NRAMP1 and DMT1. Pflugers Arch (2003) 1.06
The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Aspects Med (2013) 1.05
Effect of tenofovir on renal glomerular and tubular function. AIDS (2007) 1.05
A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab (2003) 1.03
Epithelial Ca2+ entry channels: transcellular Ca2+ transport and beyond. J Physiol (2003) 1.02
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet (2013) 1.02
Reference values and factors associated with renal resistive index in a family-based population study. Hypertension (2013) 1.00
Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells. Am J Physiol Endocrinol Metab (2008) 1.00
Circadian regulation of renal function. Kidney Int (2010) 0.99
A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule. Pflugers Arch (2010) 0.98
Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study. NMR Biomed (2006) 0.97
Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med (2013) 0.96
Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs. Anat Embryol (Berl) (2006) 0.96
Prematurity is related to high placental cortisol in preeclampsia. Pediatr Res (2009) 0.95
The sodium-dependent ascorbic acid transporter family SLC23. Mol Aspects Med (2013) 0.94
The urea transporter family (SLC14): physiological, pathological and structural aspects. Mol Aspects Med (2013) 0.94
Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT2 in rat brain. J Neurochem (2003) 0.94
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. J Am Soc Nephrol (2007) 0.93
Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol (2011) 0.93
Calcium channel TRPV6 is involved in murine maternal-fetal calcium transport. J Bone Miner Res (2008) 0.93
Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle. Am J Pathol (2010) 0.93
Kidney function: gateway to a long life? Nature (2002) 0.93
Intestinal expression of genes involved in iron absorption in humans. Am J Physiol Gastrointest Liver Physiol (2002) 0.93
Regulation of placental growth by aldosterone and cortisol. Endocrinology (2010) 0.92
Iron transport: emerging roles in health and disease. Biochem Cell Biol (2002) 0.92
Mechanisms and regulation of epithelial Ca2+ absorption in health and disease. Annu Rev Physiol (2008) 0.92
Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation (2002) 0.92
Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. FASEB J (2007) 0.91
Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem (2002) 0.91
The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist. Mol Cell Endocrinol (2004) 0.91
Calcium, vitamin D and cardiovascular disease. Kidney Blood Press Res (2011) 0.91
Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics (2011) 0.90
Salt sensitivity of children with low birth weight. Hypertension (2008) 0.90
PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant (2008) 0.89
Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol (2013) 0.89
Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells. Mol Cancer Res (2009) 0.89
Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1. FASEB J (2005) 0.88
Role of the alpha-adducin genotype on renal disease progression. Kidney Int (2002) 0.88
Inhibition of the human epithelial calcium channel TRPV6 by 2-aminoethoxydiphenyl borate (2-APB). Cell Calcium (2012) 0.88